MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

DYAI — Dyadic International, Inc.

Nasdaq

Dyadic International, Inc.

CompareBack to Screener
$0.46
+0.03(+6.10%)
O
0.46
H
0.49
L
0.44
V
141.43K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About DYAI

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateNov 5, 2004
Employees5
Stock ExchangeNasdaq
Ticker SymbolDYAI

Key Financial Statistics

Market Cap$18.26M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.34 - $1.60
52-Week Avg Volume198.4K
VWAP$0.46
Transactions1,013
Total Recorded Bars4,707 days